Works matching IS 0741238X AND DT 2023 AND VI 40 AND IP 3


Results: 37
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 3, p. 1187, doi. 10.1007/s12325-022-02408-7
    By:
    • Chouaid, Christos;
    • Bosquet, Lise;
    • Girard, Nicolas;
    • Kron, Anna;
    • Scheffler, Matthias;
    • Griesinger, Frank;
    • Sebastian, Martin;
    • Trigo, Jose;
    • Viteri, Santiago;
    • Knott, Craig;
    • Rodrigues, Bernardo;
    • Rahhali, Nora;
    • Cabrieto, Jedelyn;
    • Diels, Joris;
    • Perualila, Nolen J.;
    • Schioppa, Claudio A.;
    • Sermon, Jan;
    • Toueg, Raphael;
    • Erdmann, Nicole;
    • Mielke, Janka
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23

    GLP-1 Agonists for Weight Loss: Pharmacology and Clinical Implications.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 3, p. 723, doi. 10.1007/s12325-022-02394-w
    By:
    • Moore, Peyton W.;
    • Malone, Kevin;
    • VanValkenburg, Delena;
    • Rando, Lauren L.;
    • Williams, Brooke C.;
    • Matejowsky, Hannah G.;
    • Ahmadzadeh, Shahab;
    • Shekoohi, Sahar;
    • Cornett, Elyse M.;
    • Kaye, Alan D.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30

    Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV<sup>+</sup> PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 3, p. 1267, doi. 10.1007/s12325-022-02383-z
    By:
    • Chaganti, Sridhar;
    • Barlev, Arie;
    • Caillard, Sophie;
    • Choquet, Sylvain;
    • Cwynarski, Kate;
    • Friedetzky, Anke;
    • González-Barca, Eva;
    • Sadetsky, Natalia;
    • Schneeberger, Stefan;
    • Thirumalai, Dhanalakshmi;
    • Zinzani, Pier L.;
    • Trappe, Ralf U.
    Publication type:
    Article
    31

    Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 3, p. 869, doi. 10.1007/s12325-022-02379-9
    By:
    • Lynde, Charles;
    • Riedl, Elisabeth;
    • Maul, Julia-Tatjana;
    • Torres, Tiago;
    • Pinter, Andreas;
    • Fabbrocini, Gabrielle;
    • Daniele, Flavia;
    • Brnabic, Alan;
    • Reed, Catherine;
    • Wilhelm, Stefan;
    • Holzkämper, Thorsten;
    • Schuster, Christopher;
    • Puig, Luis
    Publication type:
    Article
    32
    33
    34
    35
    36

    Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States.

    Published in:
    Advances in Therapy, 2023, v. 40, n. 3, p. 1153, doi. 10.1007/s12325-022-02365-1
    By:
    • Huang, Min;
    • A. Fasching, Peter;
    • Haiderali, Amin;
    • Xue, Weiguang;
    • Yang, Chelsey;
    • Pan, Wilbur;
    • Zhou, Zheng-Yi;
    • Hu, Peter;
    • Chaudhuri, Mitashri;
    • Le Bailly De Tilleghem, Celine;
    • Cappoen, Nicolas;
    • O'Shaughnessy, Joyce
    Publication type:
    Article
    37